Necrotizing soft tissue infections

Critical Care Clinics

Volumn 29, Issue 4, 2013, Pages 795-806

  Hussein, Qaali A ^a   Anaya, Daniel A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clostridial infection; Gangrene; Group A streptococcal infection; Necrotizing fasciitis; Necrotizing soft tissue infections; NSTI

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; ERTAPENEM; MEROPENEM; METRONIDAZOLE; NAFCILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FROZEN SECTION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LETHALITY; MIXED INFECTION; NECROTIZING SOFT TISSUE INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND CARE;

CLOSTRIDIAL INFECTION; GANGRENE; GROUP A STREPTOCOCCAL INFECTION; NECROTIZING FASCIITIS; NECROTIZING SOFT TISSUE INFECTIONS; NSTI;

ANTI-INFECTIVE AGENTS; DEBRIDEMENT; FASCIITIS, NECROTIZING; HUMANS; SOFT TISSUE INFECTIONS;

EID: 84884973409     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2013.06.001     Document Type: Review

References (44)

1. Sarani B., Strong M., Pascual J., et al. Necrotizing fasciitis: current concepts and review of the literature. JAm Coll Surg 2009, 208(2):279-288.
2. Jones J. Surgical memoirs of the War of the Rebellion. Investigation upon thenature, causes and treatment of hospital gangrene as prevailed in the Confederate Armies 1861-1865 1871, U.S. Sanitary Commission, New York. F.H. Hamilton (Ed.).
3. Anaya D.A., Bulger E.M., Kwon Y.S., et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt) 2009, 10(6):517-522.
4. Anaya D.A., McMahon K., Nathens A.B., et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005, 140(2):151-157.
5. Wilson B. Necrotizing fasciitis. Am Surg 1952, 18(4):416-431.
6. Anaya D.A., Dellinger E.P. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007, 44(5):705-710.
7. Ellis Simonsen S.M., van Orman E.R., Hatch B.E., et al. Cellulitis incidence in a defined population. Epidemiol Infect 2006, 134(2):293-299.
8. Anaya D.A., Dellinger E.P. Necrotizing soft-tissue infection. Netter's infectious disease 2012, 273-278. Saunders, Philadelphia. 1st edition. E.C. Jong, D.L. Stevens (Eds.).
9. Callahan T.E., Schecter W.P., Horn J.K. Necrotizing soft tissue infection masquerading as cutaneous abscess following illicit drug injection. Arch Surg 1998, 133(8):812-817.
10. Chen J.L., Fullerton K.E., Flynn N.M. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001, 33(1):6-15.
11. Bosshardt T.L., Henderson V.J., Organ C.H. Necrotizing soft-tissue infections. Arch Surg 1996, 131(8):846-852.
12. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41(10):1373-1406.
13. Haywood C.T., McGeer A., Low D.E. Clinical experience with 20 cases of group Astreptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 1999, 103(6):1567-1573.
14. Elliott D.C., Kufera J.A., Myers R.A. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996, 224(5):672-683.
15. Wong C.H., Chang H.C., Pasupathy S., et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. JBone Joint Surg Am 2003, 85-A(8):1454-1460.
16. Wong C.H., Wang Y.S. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis 2005, 18(2):101-106.
17. Wall D.B., Klein S.R., Black S., et al. Asimple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. JAm Coll Surg 2000, 191(3):227-231.
18. Wong C.H., Khin L.W., Heng K.S., et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004, 32(7):1535-1541.
19. Holland M.J. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care 2009, 37(4):588-592.
20. Wysoki M.G., Santora T.A., Shah R.M., et al. Necrotizing fasciitis: CT characteristics. Radiology 1997, 203(3):859-863.
21. Struk D.W., Munk P.L., Lee M.J., et al. Imaging of soft tissue infections. Radiol Clin North Am 2001, 39(2):277-303.
22. Arslan A., Pierre-Jerome C., Borthne A. Necrotizing fasciitis: unreliable MRI findings in the preoperative diagnosis. Eur J Radiol 2000, 36(3):139-143.
23. Stamenkovic I., Lew P.D. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. NEngl J Med 1984, 310(26):1689-1693.
24. Majeski J., Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997, 90(11):1065-1068.
25. May A.K. Skin and soft tissue infections: the new surgical infection society guidelines. Surg Infect (Larchmt) 2011, 12(3):179-184.
26. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused bycommunity-associated methicillin-resistant Staphylococcus aureus in Los Angeles. NEngl J Med 2005, 352(14):1445-1453.
27. Marshall J.C., Maier R.V., Jimenez M., et al. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004, 32(Suppl 11):S513-S526.
28. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952, 13(4):389-399.
29. Stevens D.L., Gibbons A.E., Bergstrom R., et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. JInfect Dis 1988, 158(1):23-28.
30. Zimbelman J., Palmer A., Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999, 18(12):1096-1100.
31. Mulla Z.D., Leaverton P.E., Wiersma S.T. Invasive group A streptococcal infections in Florida. South Med J 2003, 96(10):968-973.
32. Stevens D.L., Bryant A.E., Hackett S.P. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis 1995, 20(Suppl 2):S154-S157.
33. McHenry C.R., Piotrowski J.J., Petrinic D., et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995, 221(5):558-563.
34. Bilton B.D., Zibari G.B., McMillan R.W., et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 1998, 64(5):397-400.
35. Lille S.T., Sato T.T., Engrav L.H., et al. Necrotizing soft tissue infections: obstacles in diagnosis. JAm Coll Surg 1996, 182(1):7-11.
36. Phan H.H., Cocanour C.S. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med 2010, 38(Suppl 9):S460-S468.
37. Ustin J.S., Malangoni M.A. Necrotizing soft-tissue infections. Crit Care Med 2011, 39(9):2156-2162.
38. Riseman J.A., Zamboni W.A., Curtis A., et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990, 108(5):847-850.
39. Jallali N., Withey S., Butler P.E. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 2005, 189(4):462-466.
40. Kaul R., McGeer A., Norrby-Teglund A., et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999, 28(4):800-807.
41. Darenberg J., Ihendyane N., Sjolin J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003, 37(3):333-340.
42. Norrby-Teglund A., Muller M.P., McGeer A., et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005, 37(3):166-172.
43. Pham T.N., Moore M.L., Costa B.A., et al. Assessment of functional limitation after necrotizing soft tissue infection. JBurn Care Res 2009, 30(2):301-306.
44. Endorf F.W., Klein M.B., Mack C.D., et al. Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers. JBurn Care Res 2008, 29(6):933-938.